INS and type 2 diabetes mellitus: Although the noted effects on insulin levels in the control group contradict the putative characteristics of leucine as an insulin secretagogue and enhancer of blood glucose disposal in patients with type 2 diabetes [37], recent evidence suggests that leucine’s effects on glucose sensitivity differ depending on physiologic context, i.e., diabetic versus non-diabetic state [38].